Based on recent data, Bioceres Crop Solutions Corp. (BIOX) shows an Average True Range (ATR) of 0.08 and an Enterprise Value of 961.11M. Its average trading volume over the past 3 months is 908.79K, indicating liquidity. These fundamental metrics provide insight into BIOX's underlying financial health and market activity.
| ATR | 0.08 |
| Enterprise Value | 961.11M |
| Avg Vol (3 Months) | 908.79K |
| Avg Vol (10 Days) | 407.49K |
Bioceres Crop Solutions Corp. (BIOX) technical indicators as of April 24, 2026: the SMA 20 is -12.44%, SMA 50 at -47.26%, and SMA 200 at -77.7%. The RSI 14 value is 28.31, suggesting its current momentum. These technical analysis signals help assess BIOX's price trends and potential future movements.
| SMA 20 | -12.44% |
| SMA 50 | -47.26% |
| SMA 200 | -77.7% |
| RSI 14 | 28.31 |
Bioceres Crop Solutions Corp. (BIOX) stock performance overview as of April 24, 2026: The 52-week high is $5.18 (currently -89.81% below), and the 52-week low is $0.347 (currently 3.99% above). Over the past year, BIOX's performance is -81.19%, compared to the S&P 500's 22.86% change.
| 52-Week High | 5.18 |
| 52-Week High Chg | -89.81% |
| 52-Week Low | 0.34715 |
| 52-Week Low Chg | +3.99% |
| S&P 500 52-Week Chg | 22.86% |
According to market data, Bioceres Crop Solutions Corp. (BIOX) stock's recent performance metrics show that over the last month, BIOX is -12.75%, with a Year-to-Date (YTD) performance of -0.76%. Over the past year, the stock has seen a -81.19% change. These figures summarize BIOX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.7 | 0.7 | 1.4 | 2.19 | 5.18 | 1.56 |
| Low | 0.5613 | 0.36 | 0.34715 | 0.34715 | 0.34715 | 0.34715 |
| Performance | +9.24% | -12.75% | -23.53% | -63.48% | -81.19% | -0.76% |
According to current financial data, BIOX stock's P/E (TTM) ratio is -0.16, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 6.66. Key valuation ratios for BIOX, including P/S (0.13), P/B (0.51), and P/FCF (0.52), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BIOX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.16 | 6.66 | 14.88 | 32.59 |
| P/S (TTM) | 0.13 | 1.56 | 3.53 | 5.98 |
| P/B (TTM) | 0.51 | 0.76 | 17.02 | 4.68 |
| P/FCF (TTM) | 0.52 | -29.65 | -2.03 | 32.51 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep